T2	intervention 24 50	home-based walking program
T3	condition 63 70	fatigue
T4	eligibility 74 122	women with breast cancer undergoing chemotherapy
T5	location 767 782	northern Taiwan
T6	eligibility 783 941	if they were diagnosed with stages I-III breast cancer and experienced insomnia, fatigue, pain, or depressive symptoms after their first cycle of chemotherapy
T7	total-participants 972 975	159
T9	control 1080 1103	attention-control group
T13	outcome 1660 1674	Fatigue levels
T1	intervention-participants 1070 1072	81
T8	control-participants 1109 1111	78
T10	outcome 1817 1824	fatigue
T14	outcome 2027 2034	fatigue
T15	outcome 2165 2222	functional performance, sleep disturbance, and depression
